Jeanine Lorusso

Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI‐2458

Gerhard Hannig, Sylvie G. Bernier, Jennifer Hoyt et al. · Arthritis & Rheumatism · 2007 · 29 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Discovery of Clinical Candidate GSK1842799 As a Selective S1P₁ Receptor Agonist (Prodrug) for Multiple Sclerosis

Hongfeng Deng, Sylvie G. Bernier, Elisabeth Doyle et al. · ACS Medicinal Chemistry Letters · 2013 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Inhibition of melanoma tumor growth by a pharmacological inhibitor of MetAP-2, PPI-2458

Gerhard Hannig, Douglas Lazarus, Sylvie G. Bernier et al. · International Journal of Oncology · 2006 · 19 citations · Full text

Medicine, Oncology, Pharmacology +16

Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists

Ghotas Evindar, Sylvie G. Bernier, Malcolm J. Kavarana et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 16 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritis

Douglas Lazarus, Elisabeth Doyle, S. G. Bernier et al. · Inflammation Research · 2008 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +13